To further validate our predictions, we overexpressed RBFOX2 in Luminal breast cells, chosen after analysis of the RBPs expression patterns across CCLE breast cell lines, confirming the same trend observed for tumour subtypes (Supplementary Fig. S6). This evidence concerns the gene RBFOX2 and neoplasm.